Atlas Trials

Comparative Study of Dorzotimol Eye Drops, 20 mg/mL + 5 mg/mL Versus Cosopt® Eye Drops, 20 mg/mL + 5 mg/mL

Clinical trial NCT05973318 · COMPLETED

Trial details

NCT number
NCT05973318
Sponsor
Jadran Galenski laboratorij d.d.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Primary Open Angle Glaucoma of Both Eyes
Start date
2017-04-10
Primary completion
2018-09-17
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.